McCarter partner Maria Laccotripe Zacharakis moderates the “Biosimilar Update” panel at the Second-Annual Intellectual Property & Innovation Conference at Suffolk University in Boston on October 29–30, 2019.
Panelists include Hans Sauer, Deputy General Counsel for Intellectual Property, BIO; Stephen J. Gaudet, Director of Intellectual Property at Regeneron Pharmaceuticals, Inc.; Bruce Leicher, former General Counsel, Momenta Pharmaceuticals, Inc.; and Jeffrey Francer, Senior Vice President & General Counsel, Association for Accessible Medicines. The conference brings together innovative IP scholars, legal practitioners, in-house counsel, trade association leaders, and policymakers to review how the law influences discoveries, creativity, and the sharing of new ideas, cures, and technologies.